2020-06-28
W World Corp., a biopharmaceutical company, announces its intention to get listed on NASDAQ on 2020/2021, opening speech by Professor Dr. OUDOM, Chairman of the W World Corp, June 28, 2020 at 0:00 a.m., New York.
W World Corp. is a globally focused biopharmaceutical company dedicated to build the global health industry chain and become a leader in the development of innovative and impactful drugs for the treatment of diseases, especially cancer diseases.
W World Corp. invests in biopharmaceutical health industry in Asia, Oceania, Australia, and Vanuatu, including the third-largest region in Europe. The company has established a long-term strategic partnership with hospitals around the world with high reputation, and started the cooperation of building 33 rehabilitation centers, striving for a new road in the field of medical treatment of cancer and other special diseases.
W World Corp. has maintained a strategic partnership with five universities in Thailand, including Royal University of South Tower, National Xi Ba Gong University, National Northeast University of Science and Technology, National Meizhou University and the National University of Technology, striving for an international breakthrough in the field of medical research, processing and extraction.
In line with the enterprise philosophy of "Serving human health all over the world", W World Corp. will be committed to building a whole health industrial chain integrating the fields of medical treatment, pharmaceutical industry, health education, and training.
Global Times: A thorough analysis of the legality of US’ tariff abuses, China's countermeasures
Global Times: Upholding the right path of multilateralism, defending the international trade order
은행들, 자금세탁방지 잰걸음…신한, 우리·하나 이어 본부 뒤늦게 격상
“미래 농업 위해 맞손”…카이스트-농식품부, AI·바이오로 혁신 시동
[르포] “300만원짜리 TV 200만원에”…폐점 앞둔 홈플러스 상동점 가보니
소진공, 쿠팡과 소상공인·전통시장 상생 업무협약